Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Cristina Teixido

Hospital Clínic de Barcelona

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain Professors in Cell Biology Cell Biology professors in Spain

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (14)

Natalia Rakislova

Associate Researcher

University of Barcelona

SPAIN

View details

Marco Tagliamento

Researcher/Assistant Professor

University of Genoa

ITALY

View details

Manel Juan

Head of Immunology service/department

Hospital Clínic de Barcelona

SPAIN

View details

Javier García-Corbacho

Head of Early Drug Development Unit

SPAIN

View details

Isabel Vilaseca González

Director

Hospital Clínic de Barcelona

SPAIN

View details

Anna Szumera-Ciećkiewicz

Head of Biobank; Senior Consultant Pathologist

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Ana Arance

University of Barcelona

SPAIN

View details

LAURA MEZQUITA

University of Barcelona

SPAIN

View details

Javier Gavira Díaz

Institut Català d'Oncologia

SPAIN

View details

CRISTINA CARRERA

Professora Agregada Titular

University of Barcelona

SPAIN

View details

Lorena Marimón

Instituto de Salud Global Barcelona

SPAIN

View details

Adriana Garcia-Herrera

Adjunct medical lecturer

University of Barcelona

SPAIN

View details

Juan Aguilar-Company

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

Elias Campo

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cristina Teixido

Research Interests

Make your next move.

Explore related searches

Articles (20)

Mucosal melanoma: clinicopathological, molecular and prognostic features in a retrospective cohort

Multicenter evaluation of the Idylla IDH1-2 Mutation Assay Kit for detection of IDH mutational status in glioma.

Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC.

Cancer stem cell biomarkers in locally advanced head and neck squamous cell carcinoma

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma

Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma

Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications

Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge

Melanoma on congenital melanocytic nevi

The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease

Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization

Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain

Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

RET Fusion Testing in Patients With NSCLC: The RETING Study.

Sex differences in patients with Non-Small Cell Lung Cancer harboring driver fusions treated with tyrosine kinase inhibitors: a systematic review

Unexpected Durable Complete Response With Anti–PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis

P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular Correlation

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (vol 5, 17499, 2015)

Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints

Collaborators (14)

Natalia Rakislova

Marco Tagliamento

Manel Juan

Javier García-Corbacho

Isabel Vilaseca González

Anna Szumera-Ciećkiewicz

Ana Arance

LAURA MEZQUITA

Javier Gavira Díaz

CRISTINA CARRERA

Lorena Marimón

Adriana Garcia-Herrera

Juan Aguilar-Company

Elias Campo

Make your next move.